By Katy Barnato
Hims & Hers Health (HERS): The telehealth company said it would stop offering compounded semaglutide, the active ingredient in weight-loss drugs Wegovy and Ozempic, after the first quarter. Hims shares dropped roughly 16% in premarket trading.
Zoom Communications (ZM): Shares fell 3% ahead of the opening bell after revenue guidance from the video-conferencing company disappointed investors.
Solventum (SOLV): Thermo Fisher Scientific $(TMO)$ is nearing a deal to buy the healthcare company's purification and filtration business. A transaction is expected to value the unit between $3.5 billion and $4 billion. Solventum was spun off from 3M last year.
Coinbase $(COIN)$, Strategy $(MSTR.AU)$ and Robinhood (HOOD): Crypto-sensitive stocks fell premarket, as bitcoin prices dropped below $90,000. Strategy, formerly known as MicroStrategy, said late Monday that it had recently bought more bitcoin.
Cleveland-Cliffs $(CLF)$: The steel maker widened its loss and logged lower sales last quarter. Chief Executive Lourenco Goncalves forecast a rebound in 2025, boosted by President Trump's policies. But shares fell roughly 4.5% premarket.
Home Depot $(HD)$ and Keurig Dr. Pepper $(KDP)$ are set to report earnings before the U.S. market opens.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
February 25, 2025 05:00 ET (10:00 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.